Andrew King

UNSW Facility Fellow (Radiochemistry)

Andrew is a Radiopharmaceutical Science Specialist with expertise in design, synthesis, and characterisation of radiotracers for diagnostic and therapeutic applications towards human health. Andrew recently completed his Ph.D. at Macquarie University in collaboration with the Australian Nuclear Science and Technology Organisation (ANSTO) in the field of radiopharmaceutical sciences. During his Ph.D. Andrew investigated new approaches to label peptide radiotracers using heteroatom-fluorine techniques as well as developing radioimmunoconjugates using both site-specific and non-site-specific approaches.

Since 2024, Andrew holds a cross appointment between the Prince of Wales Hospital and the Biological Resource Imaging Laboratory (BRIL), at UNSW as a Radiochemist. He is also a National Imaging Facility Radiochemistry Fellow. Andrew has a strong interest in developing radiotracers and radiopharmaceuticals to address challenges in research and healthcare applications.